SCM
MD icon

Saba Capital Management’s Pediatrix Medical MD Stock Holding History

Saba Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-53,700
Closed -$625K – 143
2020
Q1 		$625K Buy
+53,700
New +$1.11M 0.03% 125

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Saba Capital Management's MD Position: Q1 2025 in Review

Saba Capital Management sold out of Pediatrix Medical (MD) in Q1 2025, closing a stake of 147,590 shares — an estimated $1.94M sold.

Saba Capital Management first reported a position in MD in Q1 2020 and held it in 4 quarters. The position peaked at $2.34M in Q2 2024. 241 funds tracked by Wall St. Rank hold MD as of Q1 2025.

  • Saba Capital Management reported no remaining Pediatrix Medical position as of Q1 2025 after selling out during the quarter.
  • Saba Capital Management sold 147,590 Pediatrix Medical shares in Q1 2025, an estimated $1.94M.
  • Saba Capital Management first reported a position in Pediatrix Medical in Q1 2020 and held it in 4 quarters.
  • Saba Capital Management's Pediatrix Medical position peaked at $2.34M in Q2 2024.
  • 241 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2025.

Based on Saba Capital Management's 13F filing for Q1 2025, filed 15 May 2025.